On the 7th, Hecto Innovation announced that its consolidated sales for the first half of this year reached 215.1 billion won, with an operating profit of 27.4 billion won. This represents increases of 18.6% and 9.1%, respectively, compared to the same period last year. It marks the first time in the company's history that semi-annual sales have surpassed 200 billion won.
Second-quarter sales rose 12.0% year-on-year to 102.8 billion won, but operating profit declined by 4.0% to 12.9 billion won over the same period due to investments in launching new services.
The "multi-growth engine" strategy of simultaneously nurturing multiple businesses proved effective. In the first half, sales in Hecto Innovation's IT information services, fintech, and healthcare sectors increased by 16.8%, 18.3%, and 17.3%, respectively, compared to the same period last year.
To maximize group synergy, Hecto Innovation is working to build a stablecoin ecosystem where "wallet–payment–platform" are organically connected. The plan involves combining Hexa Financial's payment infrastructure with Hexo Wallet's wallet technology to complete a "stablecoin payment rail" that spans custody, payment, and settlement.
Hecto Healthcare, which owns the probiotic brand "Deshimone," recently received certification from the Ministry of Food and Drug Safety for its proprietary complex probiotic ingredient, confirming it can help reduce body fat. The company also obtained approval as an individually recognized health functional food ingredient. Hecto Healthcare plans to launch related new products in early next year to target the body fat management market.
Lee Hyun-cheol, CEO of Hecto Innovation, stated, "Thanks to balanced growth across all business segments, we have surpassed 200 billion won in consolidated sales for the first half. We will continue to maintain stable profitability while building a stablecoin ecosystem that connects platforms, digital asset wallets, and payment infrastructure."
in TECH
